Feedback / Questions
risvodetinib (ABLi-148009) - ABLi Therapeutics
https://www.globenewswire.com/news-release/2025/09/15/3149944/0/en/ABLi-Therapeutics-to-Present-Clinical-Breakthrough-Lecture-at-the-2025-International-Congress-of-Parkinson-s-Disease-and-Movement-Disorders.html
Sep 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next